2025-2026 Session
Change SessionH.209 (Act 53)
An act relating to intranasal epinephrine in schools
- Sponsor(s)
- Last Recorded Action
- Senate 6/13/2025 - House message: Governor approved bill on June 11, 2025
Bill/Resolution Text
- Other Text
-
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to intranasal epinephrine in schools
Detailed Status
Regular Session 2025-2026
| Body | Date | Journal | Calendar | Location | Full Status |
|---|
An act relating to intranasal epinephrine in schools
Roll Call History
Regular Session 2025-2026
| Body | Date | Journal | Location | Full Status |
|---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to intranasal epinephrine in schools
Committee Meetings
Regular Session 2025-2026
| Meeting Date | Committee |
|---|
An act relating to intranasal epinephrine in schools
Meeting Full List
Regular Session 2025-2026
Wednesday, February 19, 2025
- Committee(s):
- House Committee on Education
- 9:30 AM
-
H.209 - An act relating to intranasal epinephrine in schools
Introduction
Rep. Leslie Goldman, Sponsor
Thursday, February 27, 2025
- Committee(s):
- House Committee on Education
- 9:00 AM
-
H.209 - An act relating to intranasal epinephrine in schools
Testimony from Vermont State School Nurses Association
Kathleen Goodell, School Nurse, Westminster Center School
Kelly McGovern, President, Vermont State School Nurses Association
Thursday, March 13, 2025
- Committee(s):
- House Committee on Education
- 9:00 AM
-
H.209 - An act relating to intranasal epinephrine in schools
Mark-up
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Friday, March 14, 2025
- Committee(s):
- House Committee on Education
- 2:00 PM
-
H.209 - An act relating to intranasal epinephrine in schools
Vote
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Wednesday, April 2, 2025
- Committee(s):
- Senate Committee on Education
- 2:50 PM
-
H.209 - An act relating to intranasal epinephrine in schools
Introduction and walk-through
Rep. Leslie Goldman, Sponsor
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Thursday, April 10, 2025
- Committee(s):
- Senate Committee on Education
- 2:15 PM
-
H.209 - An act relating to intranasal epinephrine in schools
Courtney O'Brien, Interim Director of Operations, Agency of Education
Kaitlyn Kodzis, State School Nurse Consultant, Department of Health
Ilisa Stalberg, Family and Child Health Director, Department of Health
Jessica Schifano, Policy Director, Department of Health
Tuesday, May 13, 2025
- Committee(s):
- Senate Committee on Education
- 1:30 PM
-
H.209 - An act relating to intranasal epinephrine in schools
Refresher introduction to the bill.
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Wednesday, May 14, 2025
- Committee(s):
- Senate Committee on Education
- 2:00 PM
-
H.209 - An act relating to intranasal epinephrine in schools
Vote
Courtney O'Brien, Interim Director of Operations, Agency of Education
Kaitlyn Kodzis, State School Nurse Consultant, Department of Health
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Thursday, May 22, 2025
- Committee(s):
- House Committee on Education
- 2:45 PM
-
H.209 - An act relating to intranasal epinephrine in schools
Walk-through of changes proposed by Senate and of proposed amendment to define independent school nurse
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Committee Documents
An act relating to intranasal epinephrine in schools
Witnesses Who Testified
Regular Session 2025-2026
House Committee on Education
- Rep. Leslie Goldman, Sponsor
- Kathleen Goodell, School Nurse, Westminster Center School
- Kelly McGovern, President, Vermont State School Nurses Association
- Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Senate Committee on Education
- Rep. Leslie Goldman, Sponsor
- Kaitlyn Kodzis, State School Nurse Consultant, Department of Health
- Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- Courtney O'Brien, Interim Director of Operations, Agency of Education
- Jessica Schifano, Policy Director, Department of Health
- Ilisa Stalberg, Family and Child Health Director, Department of Health
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for H.209 in the Regular Session 2025-2026.
No committee of conference members found for H.209 in the Regular Session 2025-2026.
An act relating to intranasal epinephrine in schools
Committee of Conference Meetings
Regular Session 2025-2026
| Meeting Date | Committee |
|---|
An act relating to intranasal epinephrine in schools
Committee of Conference Meeting Full List
Regular Session 2025-2026
No committee of conference meeting history found for H.209 in the Regular Session 2025-2026.
No committee of conference report found for H.209 in the Regular Session 2025-2026.
Act
An act relating to intranasal epinephrine in schools
Statutes Affected
Regular Session 2025-2026
| Statute |
|---|
| 16 V.S.A. § 1388. Stock supply and emergency administration of epinephrine |
